+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hyperkalemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hyperkalemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hemophilia B - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hemophilia B - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Infantile Spasm - Epidemiology Forecast to 2032 - Product Thumbnail Image

Infantile Spasm - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Amebiasis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Amebiasis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Brucellosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Brucellosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cellulitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cellulitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pharyngitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pharyngitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Actinic Keratosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Actinic Keratosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neurodermatitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Neurodermatitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Zollinger Ellison Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pneumoconiosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pneumoconiosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Polymyalgia Rheumatica -Epidemiology Forecast -2032 - Product Thumbnail Image

Polymyalgia Rheumatica -Epidemiology Forecast -2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Inclusion Body Myositis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Inclusion Body Myositis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Venous Ulceration (CVU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Venous Ulceration (CVU) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Intestinal Obstruction - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intestinal Obstruction - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Social Anxiety Disorder (SAD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Social Anxiety Disorder (SAD) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dyschromia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Dyschromia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Galactosemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Galactosemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypoactive Sexual Desire Disorder (HSDD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypoactive Sexual Desire Disorder (HSDD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more